N-Methyl-d-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides

Geum Sil Cho, Jae Chul Lee, Chung Ju, Chunsook Kim, Won-Ki Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Inflammatory responses have been shown to modulate the pattern and degree of ischemic injury. Previously, we demonstrated that intracorpus callosum microinjection of lipopolysaccharide (LPS, a well-known endotoxin) markedly induced inflammatory responses confined to ipsilateral hemisphere and aggravated cerebral ischemic injury. Here we report that LPS injection increases the degree of N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity, one of major causes of cerebral ischemic injury. Intracorpus callosum microinjection of LPS 1 day prior to ischemic insults augmented intraneuronal Ca2+ rise in rat brains subjected to transient occlusion of middle cerebral artery. Intraperitoneal administration of memantine, a NMDA receptor antagonist, reduced the LPS-enhanced calcium response as well as ischemic tissue damage. Western blot and immunohistochemistry data showed that the level of IL-1β was enhanced in LPS-injected rat brains, particularly in isolectin-B4 immunoreactive cells. Intraventricular microinjection of recombinant rat IL-1β aggravated cerebral ischemic injury, which was significantly reduced by memantine. Intraventricular injection of anti-IL-1β antibody significantly reduced the cerebral infarction aggravated by LPS preinjection. The results indicate that IL-1β released from isolectin-B4 immunoreactive cells enhanced excitotoxicity, consequently aggravating ischemic brain injury.

Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalNeuroscience Letters
Volume538
DOIs
Publication statusPublished - 2013 Mar 22

Fingerprint

Memantine
Dizocilpine Maleate
Interleukin-1
Lipopolysaccharides
Microinjections
Injections
Wounds and Injuries
Lectins
Intraventricular Injections
Middle Cerebral Artery Infarction
Cerebral Infarction
Brain
Cerebrum
Endotoxins
Brain Injuries
Western Blotting
Immunohistochemistry
Calcium
aspartic acid receptor
Antibodies

Keywords

  • Excitotoxicity
  • Interleukin-1β
  • Ischemia
  • Lipopolysaccharides
  • Memantine
  • Middle cerebral artery occlusion
  • N-Methyl-d-aspartate
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

N-Methyl-d-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides. / Cho, Geum Sil; Lee, Jae Chul; Ju, Chung; Kim, Chunsook; Kim, Won-Ki.

In: Neuroscience Letters, Vol. 538, 22.03.2013, p. 9-14.

Research output: Contribution to journalArticle

@article{121b445d59e141eca1d5e18cf9454b37,
title = "N-Methyl-d-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides",
abstract = "Inflammatory responses have been shown to modulate the pattern and degree of ischemic injury. Previously, we demonstrated that intracorpus callosum microinjection of lipopolysaccharide (LPS, a well-known endotoxin) markedly induced inflammatory responses confined to ipsilateral hemisphere and aggravated cerebral ischemic injury. Here we report that LPS injection increases the degree of N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity, one of major causes of cerebral ischemic injury. Intracorpus callosum microinjection of LPS 1 day prior to ischemic insults augmented intraneuronal Ca2+ rise in rat brains subjected to transient occlusion of middle cerebral artery. Intraperitoneal administration of memantine, a NMDA receptor antagonist, reduced the LPS-enhanced calcium response as well as ischemic tissue damage. Western blot and immunohistochemistry data showed that the level of IL-1β was enhanced in LPS-injected rat brains, particularly in isolectin-B4 immunoreactive cells. Intraventricular microinjection of recombinant rat IL-1β aggravated cerebral ischemic injury, which was significantly reduced by memantine. Intraventricular injection of anti-IL-1β antibody significantly reduced the cerebral infarction aggravated by LPS preinjection. The results indicate that IL-1β released from isolectin-B4 immunoreactive cells enhanced excitotoxicity, consequently aggravating ischemic brain injury.",
keywords = "Excitotoxicity, Interleukin-1β, Ischemia, Lipopolysaccharides, Memantine, Middle cerebral artery occlusion, N-Methyl-d-aspartate, Stroke",
author = "Cho, {Geum Sil} and Lee, {Jae Chul} and Chung Ju and Chunsook Kim and Won-Ki Kim",
year = "2013",
month = "3",
day = "22",
doi = "10.1016/j.neulet.2013.01.031",
language = "English",
volume = "538",
pages = "9--14",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - N-Methyl-d-aspartate receptor antagonists memantine and MK-801 attenuate the cerebral infarct accelerated by intracorpus callosum injection of lipopolysaccharides

AU - Cho, Geum Sil

AU - Lee, Jae Chul

AU - Ju, Chung

AU - Kim, Chunsook

AU - Kim, Won-Ki

PY - 2013/3/22

Y1 - 2013/3/22

N2 - Inflammatory responses have been shown to modulate the pattern and degree of ischemic injury. Previously, we demonstrated that intracorpus callosum microinjection of lipopolysaccharide (LPS, a well-known endotoxin) markedly induced inflammatory responses confined to ipsilateral hemisphere and aggravated cerebral ischemic injury. Here we report that LPS injection increases the degree of N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity, one of major causes of cerebral ischemic injury. Intracorpus callosum microinjection of LPS 1 day prior to ischemic insults augmented intraneuronal Ca2+ rise in rat brains subjected to transient occlusion of middle cerebral artery. Intraperitoneal administration of memantine, a NMDA receptor antagonist, reduced the LPS-enhanced calcium response as well as ischemic tissue damage. Western blot and immunohistochemistry data showed that the level of IL-1β was enhanced in LPS-injected rat brains, particularly in isolectin-B4 immunoreactive cells. Intraventricular microinjection of recombinant rat IL-1β aggravated cerebral ischemic injury, which was significantly reduced by memantine. Intraventricular injection of anti-IL-1β antibody significantly reduced the cerebral infarction aggravated by LPS preinjection. The results indicate that IL-1β released from isolectin-B4 immunoreactive cells enhanced excitotoxicity, consequently aggravating ischemic brain injury.

AB - Inflammatory responses have been shown to modulate the pattern and degree of ischemic injury. Previously, we demonstrated that intracorpus callosum microinjection of lipopolysaccharide (LPS, a well-known endotoxin) markedly induced inflammatory responses confined to ipsilateral hemisphere and aggravated cerebral ischemic injury. Here we report that LPS injection increases the degree of N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity, one of major causes of cerebral ischemic injury. Intracorpus callosum microinjection of LPS 1 day prior to ischemic insults augmented intraneuronal Ca2+ rise in rat brains subjected to transient occlusion of middle cerebral artery. Intraperitoneal administration of memantine, a NMDA receptor antagonist, reduced the LPS-enhanced calcium response as well as ischemic tissue damage. Western blot and immunohistochemistry data showed that the level of IL-1β was enhanced in LPS-injected rat brains, particularly in isolectin-B4 immunoreactive cells. Intraventricular microinjection of recombinant rat IL-1β aggravated cerebral ischemic injury, which was significantly reduced by memantine. Intraventricular injection of anti-IL-1β antibody significantly reduced the cerebral infarction aggravated by LPS preinjection. The results indicate that IL-1β released from isolectin-B4 immunoreactive cells enhanced excitotoxicity, consequently aggravating ischemic brain injury.

KW - Excitotoxicity

KW - Interleukin-1β

KW - Ischemia

KW - Lipopolysaccharides

KW - Memantine

KW - Middle cerebral artery occlusion

KW - N-Methyl-d-aspartate

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84875121915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875121915&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2013.01.031

DO - 10.1016/j.neulet.2013.01.031

M3 - Article

VL - 538

SP - 9

EP - 14

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -